| Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial N Sprigg, K Flaherty, JP Appleton, RAS Salman, D Bereczki, M Beridze, ... The Lancet 391 (10135), 2107-2115, 2018 | 439 | 2018 |
| Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 285 | 2019 |
| Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2 … D Wilson, G Ambler, C Shakeshaft, MM Brown, A Charidimou, ... The Lancet Neurology 17 (6), 539-547, 2018 | 252 | 2018 |
| Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint … CS Anderson, Y Huang, RI Lindley, X Chen, H Arima, G Chen, Q Li, ... The Lancet 393 (10174), 877-888, 2019 | 240 | 2019 |
| A systematic review of cannabidiol dosing in clinical populations SA Millar, NL Stone, ZD Bellman, AS Yates, TJ England, SE O'Sullivan British journal of clinical pharmacology 85 (9), 1888-1900, 2019 | 229 | 2019 |
| A novel transwell blood brain barrier model using primary human cells NL Stone, TJ England, SE O’Sullivan Frontiers in cellular neuroscience 13, 230, 2019 | 222 | 2019 |
| Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... The Lancet 393 (10191), 2613-2623, 2019 | 187 | 2019 |
| Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a … PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ... The Lancet 391 (10123), 850-859, 2018 | 186 | 2018 |
| Cannabidiol protects an in vitro model of the blood–brain barrier from oxygen‐glucose deprivation via PPARγ and 5‐HT1A receptors WH Hind, TJ England, SE O'Sullivan British journal of pharmacology 173 (5), 815-825, 2016 | 176 | 2016 |
| RECAST (remote ischemic conditioning after stroke trial) a pilot randomized placebo controlled phase II trial in acute ischemic stroke TJ England, A Hedstrom, S O’Sullivan, R Donnelly, DA Barrett, S Sarmad, ... Stroke 48 (5), 1412-1415, 2017 | 175 | 2017 |
| Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies D Wilson, G Ambler, KJ Lee, JS Lim, M Shiozawa, M Koga, L Li, ... The Lancet Neurology 18 (7), 653-665, 2019 | 174 | 2019 |
| Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial PM Bath, P Scutt, CS Anderson, JP Appleton, E Berge, L Cala, M Dixon, ... The Lancet 393 (10175), 1009-1020, 2019 | 166 | 2019 |
| Outcome of intracerebral hemorrhage associated with different oral anticoagulants D Wilson, DJ Seiffge, C Traenka, G Basir, JC Purrucker, T Rizos, ... Neurology 88 (18), 1693-1700, 2017 | 161 | 2017 |
| Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in … C Geeganage, M Tracy, T England, G Sare, T Moulin, F Woimant, ... Stroke 42 (2), 491-493, 2011 | 135 | 2011 |
| Colony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for stroke PMW Bath, N Sprigg, T England Cochrane Database of Systematic Reviews, 2013 | 131 | 2013 |
| Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled … TJ England, M Abaei, DP Auer, J Lowe, DRE Jones, G Sare, M Walker, ... Stroke 43 (2), 405-411, 2012 | 120 | 2012 |
| Endocannabinoids modulate human blood–brain barrier permeability in vitro WH Hind, C Tufarelli, M Neophytou, SI Anderson, TJ England, ... British journal of pharmacology 172 (12), 3015-3027, 2015 | 108 | 2015 |
| Smoking cessation and outcome after ischemic stroke or TIA KA Epstein, CM Viscoli, JD Spence, LH Young, SE Inzucchi, M Gorman, ... Neurology 89 (16), 1723-1729, 2017 | 102 | 2017 |
| Cannabinoids in experimental stroke: a systematic review and meta-analysis TJ England, WH Hind, NA Rasid, SE O'sullivan Journal of Cerebral Blood Flow & Metabolism 35 (3), 348-358, 2015 | 98 | 2015 |
| Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: a systematic review TJ England, CL Gibson, PMW Bath Brain research reviews 62 (1), 71-82, 2009 | 92 | 2009 |
Philip BathStroke Association Professor of Stroke Medicine, University of Nottingham在 nottingham.ac.uk 的电子邮件经过验证
